Divided FTC conditionally clears Danaher/GE biopharma merger

Spencer Parts

20 March 2020

Divided FTC conditionally clears Danaher/GE biopharma merger

Shutterstock/Casimiro PT

Danaher must divest products in several markets to allay concerns that its $21 billion acquisition of GE’s biopharma business would harm competition, the Federal Trade Commission has held.